Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

View all →   RSSRecent Releases
Mar 17, 2015 Celldex Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate the Combination of Varlilumab and MPDL3280A
Mar 3, 2015 Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference
What's New

2012 Form 10-K

More →Upcoming Events
Details on upcoming events are not yet available.
Featured Financial Reports
Filing Date Title Type Size
Nov 5, 2014 Form 10-Q View HTML View PDF 559.6 KB Add to Briefcase
Feb 24, 2015 Form 10-K View HTML View PDF 1.1 MB Add to Briefcase
Add to Briefcase = add file to Briefcase